1. Pharmaceutical Research and Manufacturers of America (PhRMA). New Medicines in Development for Mental Illness. PhRMA web site [online] , (2006).
2. Pharmaceutical Research and Manufacturers of America (PhRMA). New Medicines in Development for Neurological Disorders. PhRMA web site [online] , (2006).
3. Ferri, C. P. et al. Global prevalence of dementia: a Delphi consensus study. Lancet 366, 2112–2117 (2005).
4. Kola, I. & Landis, J. Can the pharmaceutical industry reduce attrition rates? Nature Rev. Drug Discov. 3, 711–715 (2004).
5. Tufts Center for the Study of Drug Development. Longer clinical times are extending time to market for new drugs in US. Tufts CSDD Impact Report 7, 1–4 (2005).